| 1 |
23721517 | Quantum dots self assembly based interface for blood cancer detection. | 2013 Jul 9 |
1 |
| 2 |
22647531 | Chitosan encapsulated quantum dots platform for leukemia detection. | 2012 Oct-Dec |
1 |
| 3 |
22772337 | Photocleavable peptide-oligonucleotide conjugates for protein kinase assays by MALDI-TOF MS. | 2012 Sep |
1 |
| 4 |
17160016 | Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells. | 2007 May 24 |
1 |
| 5 |
17488685 | Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis. | 2007 May |
1 |
| 6 |
16891454 | Antisense locked nucleic acids efficiently suppress BCR/ABL and induce cell growth decline and apoptosis in leukemic cells. | 2006 Jul |
1 |
| 7 |
15592617 | Synthesis of N3- and 2-NH2-substituted 6,7-diphenylpterins and their use as intermediates for the preparation of oligonucleotide conjugates designed to target photooxidative damage on single-stranded DNA representing the bcr-abl chimeric gene. | 2004 Dec 21 |
1 |
| 8 |
15631652 | [Identification bcr-abl fusion gene in leukemia cells with oligonucleotide microarray]. | 2004 Dec |
1 |
| 9 |
12661602 | Targeting of photooxidative damage on single-stranded DNA representing the bcr-abl chimeric gene using oligonucleotide-conjugates containing [Ru(phen)3](2+)-like photosensitiser groups. | 2002 Dec |
1 |
| 10 |
10099134 | Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosome. | 1999 Apr |
1 |
| 11 |
10390076 | Antisense strategy in hematological malignancies. | 1999 Mar |
1 |
| 12 |
10419896 | A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct. | 1999 Aug 1 |
1 |
| 13 |
10583226 | BCR-ABL influences the antileukaemic efficacy of alkylphosphocholines. | 1999 Nov |
2 |
| 14 |
9525737 | Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL. | 1998 Mar |
1 |
| 15 |
9558345 | The DNA binding domain of the human c-Abl tyrosine kinase preferentially binds to DNA sequences containing an AAC motif and to distorted DNA structures. | 1998 Apr 28 |
1 |
| 16 |
9639422 | Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. | 1998 Jun |
1 |
| 17 |
9029029 | An antisense Bcr-Abl phosphodiester-tailed methylphosphonate oligonucleotide reduces the growth of chronic myeloid leukaemia patient cells by a non-antisense mechanism. | 1997 Feb |
4 |
| 18 |
8649049 | The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia. | 1996 Jun |
1 |
| 19 |
8709619 | The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells. | 1996 Jun |
1 |
| 20 |
8798460 | Binding of A/T-rich DNA by three high mobility group-like domains in c-Abl tyrosine kinase. | 1996 Sep 13 |
4 |
| 21 |
7545682 | Regulation of the Fas apoptotic cell death pathway by Abl. | 1995 Sep 22 |
2 |
| 22 |
7579442 | Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors. | 1995 Nov 1 |
1 |
| 23 |
7812014 | Specificity of BCR-ABL antisense oligonucleotides. | 1995 Jan 15 |
1 |
| 24 |
7845006 | Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels. | 1995 Jan |
1 |
| 25 |
8535187 | BCR-ABL: an anti-apoptosis gene in chronic myelogenous leukemia. | 1995 Jul |
1 |
| 26 |
8542954 | Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction. | 1995 Dec |
3 |
| 27 |
8590842 | Specific antisense oligomer anti Bcr-abl junctions in chronic myeloid leukemia: a cell cycle analysis and CFU-GM study. | 1995 Nov |
1 |
| 28 |
7524739 | Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor. | 1994 Nov 15 |
1 |
| 29 |
8063271 | Meeting report: antisense oligonucleotides. | 1994 Mar-Apr |
2 |
| 30 |
8118022 | BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. | 1994 Mar 1 |
1 |
| 31 |
8161775 | Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. | 1994 Apr 15 |
1 |
| 32 |
8207957 | Capping of bcr-abl antisense oligonucleotides enhances antiproliferative activity against chronic myeloid leukemia cell lines. | 1994 Jun |
2 |
| 33 |
8289478 | Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173. | 1994 Jan |
2 |
| 34 |
8329715 | Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line. | 1993 Jul 15 |
1 |
| 35 |
8479075 | [Recent advances in molecular cytogenetics of leukemia]. | 1993 Mar |
1 |
| 36 |
8500581 | Human Philadelphia chromosome-positive chronic myeloid leukemia: a potential model for antisense therapy. | 1993 Jun |
1 |
| 37 |
27457438 | Inhibition of P210BCR/ABL Expression in K562 Cells by Electroporation with an Antisense Oligonucleotide. | 1990 |
2 |